Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Wyeth |
---|---|
Information provided by: | Wyeth |
ClinicalTrials.gov Identifier: | NCT00311350 |
This is the first multiple-dose experience in humans with MOA-728 in an oral formulation. This study will provide an assessment of the safety, tolerability, and pharmacokinetics (PK) of MOA-728 following administration of ascending multiple oral doses to healthy subjects.
Condition | Intervention | Phase |
---|---|---|
Postoperative Complications Constipation |
Drug: MOA-728 |
Phase I |
Study Type: | Interventional |
Study Design: | Randomized, Double-Blind, Placebo Control, Safety Study |
Official Title: | Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of MOA-728 Administered Orally to Healthy Subjects |
Ages Eligible for Study: | 18 Years to 50 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria: - Healthy men and women
Study ID Numbers: | 3200A3-100 |
Study First Received: | April 3, 2006 |
Last Updated: | March 30, 2007 |
ClinicalTrials.gov Identifier: | NCT00311350 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Safety Health Pharmacokinetics ileus |
Signs and Symptoms Ileus Signs and Symptoms, Digestive |
Postoperative Complications Constipation Healthy |
Signs and Symptoms Pathologic Processes Signs and Symptoms, Digestive Postoperative Complications Constipation |